Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Aug 8, 2023
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-08-04+195,000→ 195,000 totalExercise: $85.82Exp: 2031-01-04→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]On January 4, 2021, the reporting person was granted an option to purchase 650,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on August 4, 2023, resulting in the vesting of the option as to 195,000 shares.